↓ Skip to main content

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports

Overview of attention for article published in Clinical Diabetes and Endocrinology, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

blogs
1 blog
twitter
4 X users

Readers on

mendeley
88 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
Published in
Clinical Diabetes and Endocrinology, January 2019
DOI 10.1186/s40842-018-0073-4
Pubmed ID
Authors

Meng H. Tan, Ravi Iyengar, Kara Mizokami-Stout, Sarah Yentz, Mark P. MacEachern, Li Yan Shen, Bruce Redman, Roma Gianchandani

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 13%
Researcher 10 11%
Student > Master 10 11%
Student > Doctoral Student 5 6%
Student > Ph. D. Student 5 6%
Other 14 16%
Unknown 33 38%
Readers by discipline Count As %
Medicine and Dentistry 39 44%
Nursing and Health Professions 6 7%
Agricultural and Biological Sciences 2 2%
Social Sciences 2 2%
Psychology 2 2%
Other 4 5%
Unknown 33 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 May 2023.
All research outputs
#3,369,060
of 23,923,788 outputs
Outputs from Clinical Diabetes and Endocrinology
#22
of 83 outputs
Outputs of similar age
#79,012
of 442,709 outputs
Outputs of similar age from Clinical Diabetes and Endocrinology
#3
of 4 outputs
Altmetric has tracked 23,923,788 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 83 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.4. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,709 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.